FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/20/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/20/2017     P    2000   A $0.0648   23916189   D    
Common Stock   10/20/2017     P    2000   A $0.065   23918189   D    
Common Stock   10/20/2017     P    3000   A $0.0681   23921189   D    
Common Stock   10/20/2017     P    1476   A $0.0665   23922665   D    
Common Stock   10/20/2017     P    1524   A $0.0665   23924189   D    
Common Stock   10/20/2017     P    2000   A $0.0665   23926189   D    
Common Stock   10/20/2017     P    2000   A $0.06   23928189   D    
Common Stock   10/20/2017     P    2000   A $0.06   23930189   D    
Common Stock   10/20/2017     P    2000   A $0.06   23932189   D    
Common Stock   10/20/2017     P    2000   A $0.0595   23934189   D    
Common Stock   10/20/2017     P    2000   A $0.0594   23936189   D    
Common Stock   10/20/2017     P    3000   A $0.0595   23939189   D    
Common Stock   10/20/2017     P    3000   A $0.0595   23942189   D    
Common Stock   10/20/2017     P    2000   A $0.0595   23944189   D    
Common Stock   10/20/2017     P    2000   A $0.06   23946189   D    
Common Stock   10/20/2017     P    2000   A $0.059   23948189   D    
Common Stock   10/20/2017     P    3000   A $0.0547   23951189   D    
Common Stock   10/20/2017     P    3000   A $0.0559   23954189   D    
Common Stock   10/20/2017     P    3000   A $0.0559   23957189   D    
Common Stock   10/20/2017     P    3000   A $0.0533   23960189   D    
Common Stock   10/20/2017     P    3000   A $0.0521   23963189   D    
Common Stock   10/20/2017     P    3000   A $0.0539   23966189   D    
Common Stock   10/20/2017     P    3000   A $0.055   23972189   D    
Common Stock   10/20/2017     P    3000   A $0.0556   23975189   D    
Common Stock   10/20/2017     P    3000   A $0.0555   23978189   D    
Common Stock   10/20/2017     P    3000   A $0.0555   23981189   D    
Common Stock   10/20/2017     P    3000   A $0.0555   23984189   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Scott Mann 10/26/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.